Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KREUTER, J")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 160

  • Page / 7
Export

Selection :

  • and

ON THE MECHANISM OF TERMINATION IN HETEROGENEOUS POLYMERIZATIONKREUTER J.1982; J. POLYM. SCI., POLYM. LETT. ED.; ISSN 0360-6384; USA; DA. 1982; VOL. 20; NO 10; PP. 543-545; BIBL. 11 REF.Article

NEW ADJUVANTS ON A POLYMETHYL METHACRYLATE BASEKREUTER J; SPEISER PP.1976; INFECT. AND IMMUN.; U.S.A.; DA. 1976; VOL. 13; NO 1; PP. 204-210; BIBL. 18 REF.Article

Peroral administration of nanoparticlesKREUTER, J.Advanced drug delivery reviews. 1991, Vol 7, Num 1, pp 71-86, issn 0169-409X, 16 p.Article

LONG-TERM STUDIES OF MICROENCAPSULATED AND ADSORBED INFLUENZA VACCINE NANOPARTICLESKREUTER J; LIEHL E.1981; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1981; VOL. 70; NO 4; PP. 367-371; BIBL. 21 REF.Article

IMPROVED DELIVERY OF METHOXSALENKREUTER J; HIGUCHI T.1979; J. PHARM. SCI.; USA; DA. 1979; VOL. 68; NO 4; PP. 451-454; BIBL. 18 REF.Article

Possibilities of using nanoparticles as carriers for drugs and vaccinesKREUTER, J.Journal of microencapsulation. 1988, Vol 5, Num 2, pp 115-127, issn 0265-2048Article

MODE OF ACTION OF IMMUNOLOGICAL ADJUVANTS: SOME PHYSICOCHEMICAL FACTORS INFLUENCING THE EFFECTIVITY OF POLYACRYLIC ADJUVANTS.KREUTER J; HAENZEL I.1978; INFECT. AND IMMUN.; U.S.A.; DA. 1978; VOL. 19; NO 2; PP. 667-675; BIBL. 1 P. 1/2Article

PROTECTION INDUCED BY INACTIVATED INFLUENZA VIRUS VACCINES WITH POLYMETHYLMETHACRYLATE ADJUVANTS.KREUTER J; LIEHL E.1978; MED. MICROBIOL. IMMUNOL.; DEU; DA. 1978; VOL. 165; NO 2; PP. 111-117; BIBL. 20 REF.Article

Drug targeting with nanoparticlesKREUTER, J.European journal of drug metabolism and pharmacokinetics. 1994, Vol 19, Num 3, pp 253-256, issn 0378-7966Conference Paper

Injectable matrix systemsKREUTER, J.S.T.P. pharma. 1987, Vol 3, Num 4, pp 303-307Conference Paper

THE USE OF 60CO-GAMMA -IRRADIATION FOR THE PRODUCTION OF VACCINES.KREUTER J; ZEHNDER HJ.1978; RAD. EFFECTS; G.B.; DA. 1978; VOL. 35; NO 3; PP. 161-166; BIBL. 33 REF.Article

IN VITRO STUDIES OF POLY (METHYL METHACRYLATE) ADJUVANTS.KREUTER J; SPEISER PP.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 11; PP. 1624-1627; BIBL. 8 REF.Article

Large-scale production problems and manufacturing of nanoparticlesKREUTER, J.Drugs and the pharmaceutical sciences. 1990, Vol 41, pp 257-266, issn 0360-2583, 10 p.Article

MOLECULAR WEIGHTS OF POLY (METHYL METHACRYLATE) NANOPARTICLESBENTELE V; BERG VE; KREUTER J et al.1982; INTERNATIONAL JOURNAL OF PHARMACEUTICS; ISSN 0378-5173; NLD; DA. 1982; VOL. 13; NO 1; PP. 109-113; BIBL. 10 REF.Article

Warum liebte Isaak Esau? Uberlegungen zu b-pyw in Gen 25, 28 Pourquoi Isaac aimait-il Esaü?KREUTER, J. A.Biblische Notizen. 1989, Num 48, pp 17-18, issn 0178-2967Article

MOLECULAR WEIGHTS OF POLYCYANOACRYLATE NANOPARTICLESEL EGAKEY MA; BENTELE V; KREUTER J et al.1983; INT. J. PHARM.; ISSN 0378-5173; NLD; DA. 1983; VOL. 13; NO 3; PP. 349-352; BIBL. 6 REF.Article

PROBLEMATIK DER IN-VITRO-FREIGABE AM BEISPIEL VON 8-METHOXY-PSORALEN = LE PROBLEME DE LA LIBERATION IN VITRO SUR L'EXEMPLE DU METHOXY-8 PSORALENEPRASAD K; VAIZOGLU O; KREUTER J et al.1980; ACTA PHARM. TECHNOL.; ISSN 0340-3157; DEU; DA. 1980; VOL. 26; NO 4; PP. 316-317; BIBL. 8 REF.Article

DISTRIBUTION AND ELIMINATION OF POLY(METHYL-2-14C-METHACRYLATE) NANOPARTICLE RADIOACTIVITY AFTER INJECTION IN RATS AND MICEKREUTER J; TAUBER U; ILLI V et al.1979; J. PHARM. SCI.; USA; DA. 1979; VOL. 68; NO 11; PP. 1443-1447; BIBL. 20 REF.Article

Effecdt of nonionic surfactants on transdermal drug delivery. I, PomysorbatesCAPPEL, M. J; KREUTER, J.International journal of pharmaceutics. 1991, Vol 69, Num 2, pp 143-153, issn 0378-5173, 11 p.Article

Effect of nonionic surfactants on transdermal drug delivery. II, Poloxamer and poloxamer and poloxamine surfactantsCAPPEL, M. J; KREUTER, J.International journal of pharmaceutics. 1991, Vol 69, Num 2, pp 155-167, issn 0378-5173, 13 p.Article

The role of serum complement on the organ distribution of intravenously administered poly (methyl methacrylate) nanoparticles : Effects of pre-coating with plasma and with serum complementBORCHARD, G; KREUTER, J.Pharmaceutical research. 1996, Vol 13, Num 7, pp 1055-1058, issn 0724-8741Article

Contact angles of surfactants with a potential to alter the body distribution of colloidal drug carriers on poly(methyl methacrylate) surfacesTRÖSTER, S. D; KREUTER, J.International journal of pharmaceutics. 1988, Vol 45, Num 1-2, pp 91-100, issn 0378-5173Article

POLYBUTYLCYANOACRYLATE NANOPARTICLES FOR THE DELIVERY OF (75SE) NORCHOLESTENOLKREUTER J; MILLS SN; DAVIS SS et al.1983; INTERNATIONAL JOURNAL OF PHARMACEUTICS; ISSN 0378-5173; NLD; DA. 1983; VOL. 16; NO 1; PP. 105-113; BIBL. 13 REF.Article

Optimization of the preparation of loperamide-loaded poly (L-lactide) nanoparticles by high pressure emulsification-solvent evaporationUEDA, M; KREUTER, J.Journal of microencapsulation. 1997, Vol 14, Num 5, pp 593-605, issn 0265-2048Article

Influence of various penetration enhancers on the in vitro permeation of amino acids across hairless mouse skinRULAND, A; KREUTER, J.International journal of pharmaceutics. 1992, Vol 85, Num 1-3, pp 7-17, issn 0378-5173Article

  • Page / 7